Logo image of OMEX

ODYSSEY MARINE EXPLORATION (OMEX) Stock Fundamental Analysis

NASDAQ:OMEX - Nasdaq - US6761182012 - Common Stock - Currency: USD

0.48  -0.01 (-1.58%)

After market: 0.4715 -0.01 (-1.77%)

Fundamental Rating

1

OMEX gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. OMEX may be in some trouble as it scores bad on both profitability and health. OMEX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

OMEX had positive earnings in the past year.
In the past 5 years OMEX reported 4 times negative net income.
In the past 5 years OMEX always reported negative operating cash flow.
OMEX Yearly Net Income VS EBIT VS OCF VS FCFOMEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M -5M -10M -15M -20M

1.2 Ratios

OMEX has a Return On Assets of 119.52%. This is amongst the best in the industry. OMEX outperforms 100.00% of its industry peers.
Industry RankSector Rank
ROA 119.52%
ROE N/A
ROIC N/A
ROA(3y)-87.51%
ROA(5y)-116.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OMEX Yearly ROA, ROE, ROICOMEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200

1.3 Margins

With an excellent Profit Margin value of 1810.52%, OMEX belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Operating Margin and Gross Margin are not available for OMEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 1810.52%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OMEX Yearly Profit, Operating, Gross MarginsOMEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 -500 -1K -1.5K

0

2. Health

2.1 Basic Checks

OMEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OMEX has more shares outstanding
The number of shares outstanding for OMEX has been increased compared to 5 years ago.
OMEX has a better debt/assets ratio than last year.
OMEX Yearly Shares OutstandingOMEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
OMEX Yearly Total Debt VS Total AssetsOMEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

2.2 Solvency

OMEX has an Altman-Z score of -22.14. This is a bad value and indicates that OMEX is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -22.14, OMEX is doing worse than 96.34% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -22.14
ROIC/WACCN/A
WACC4.53%
OMEX Yearly LT Debt VS Equity VS FCFOMEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

2.3 Liquidity

OMEX has a Current Ratio of 0.10. This is a bad value and indicates that OMEX is not financially healthy enough and could expect problems in meeting its short term obligations.
OMEX has a worse Current ratio (0.10) than 97.56% of its industry peers.
A Quick Ratio of 0.10 indicates that OMEX may have some problems paying its short term obligations.
With a Quick ratio value of 0.10, OMEX is not doing good in the industry: 97.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.1
Quick Ratio 0.1
OMEX Yearly Current Assets VS Current LiabilitesOMEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

1

3. Growth

3.1 Past

OMEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 119.83%, which is quite impressive.
Looking at the last year, OMEX shows a very negative growth in Revenue. The Revenue has decreased by -39.56% in the last year.
Measured over the past years, OMEX shows a very negative growth in Revenue. The Revenue has been decreasing by -24.52% on average per year.
EPS 1Y (TTM)119.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)-39.56%
Revenue growth 3Y-26.69%
Revenue growth 5Y-24.52%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OMEX Yearly Revenue VS EstimatesOMEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
OMEX Yearly EPS VS EstimatesOMEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 -1 -2 -3 -4

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.45 indicates a rather cheap valuation of OMEX.
Compared to the rest of the industry, the Price/Earnings ratio of OMEX indicates a rather cheap valuation: OMEX is cheaper than 100.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.63, OMEX is valued rather cheaply.
Industry RankSector Rank
PE 0.45
Fwd PE N/A
OMEX Price Earnings VS Forward Price EarningsOMEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OMEX Per share dataOMEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for OMEX!.
Industry RankSector Rank
Dividend Yield N/A

ODYSSEY MARINE EXPLORATION

NASDAQ:OMEX (2/21/2025, 8:00:01 PM)

After market: 0.4715 -0.01 (-1.77%)

0.48

-0.01 (-1.58%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)N/A N/A
Earnings (Next)05-05 2025-05-05
Inst Owners16.3%
Inst Owner Change-23.16%
Ins Owners3.68%
Ins Owner Change8.13%
Market Cap13.98M
Analysts82.86
Price TargetN/A
Short Float %6.47%
Short Ratio1.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.45
Fwd PE N/A
P/S 9.73
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)1.06
EY220.83%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.05
BVpS-0.55
TBVpS-0.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 119.52%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1810.52%
GM N/A
FCFM N/A
ROA(3y)-87.51%
ROA(5y)-116.87%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.1
Quick Ratio 0.1
Altman-Z -22.14
F-ScoreN/A
WACC4.53%
ROIC/WACCN/A
Cap/Depr(3y)751.45%
Cap/Depr(5y)454.2%
Cap/Sales(3y)90.41%
Cap/Sales(5y)54.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)119.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-39.56%
Revenue growth 3Y-26.69%
Revenue growth 5Y-24.52%
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y39.33%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-8.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.95%
OCF growth 3YN/A
OCF growth 5YN/A